News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Retrophin, Inc. (RTRX) Names Alvin Shih, M.D. Executive Vice President Of Research And Development


5/29/2014 8:04:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Retrophin, Inc. (NASDAQ:RTRX) today announced the hiring of Alvin Shih, M.D. as Executive Vice President of Research and Development, effective June 2, 2014. In this role, he will oversee all medical, clinical and research functions. Dr. Shih joins Retrophin from Pfizer Inc. (NYSE:PFE), where he was Chief Operating Officer of the Rare Disease Research Unit.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES